A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Informazioni sui farmaci
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Current Oncology | Free Full-Text | Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial | NEJM
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 11 (2020)
Fibrosi polmonare idiopatica: su NEJM studio su una nuova terapia, coordinato da Luca Richeldi - Policlinico Universitario A. Gemelli IRCCS
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Cancer Clinical Trial Interpretation Videos - YouTube
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation | NEJM
David Vivas on X: "🚨SECURE TRIAL now on NEJM! Polypill better than usual care in secondary prevention after MI! Spanish Investigation on top of @escardio 🇪🇸 Congrats Dr Castellano @CNIC_CARDIO and thnks
Monumen-TAL - I dismantle the ASH/ NEJM Talquetamab study | First of the ASH 2022 video series - YouTube
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | NEJM
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM
NEJM on X: "The POLO trial evaluated the efficacy of maintenance therapy with olaparib in patients with a germline BRCA mutation and metastatic pancreatic adenocarcinoma that had not progressed during first-line platinum-based
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation | British Journal of Cancer
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
10 1056@NEJMoa2028220 PDF | PDF | Myocardial Infarction | High Density Lipoprotein
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
Noninvasive Imaging Heisenberg Research Group – Heisenberg Radiology Research group of Marc Dewey
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer | NEJM
Diapositiva 1
Genes | Free Full-Text | Personalized Systemic Therapies in Hereditary Cancer Syndromes
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
